Myocardial Infarction Prediction
Primary Purpose
Myocardial Infarction, Artificial Neural Network
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
ANN prediction of myocardial infarction
Sponsored by
![Shiraz University of Medical Sciences](https://trials-media.s3.amazonaws.com/orgs/shiraz-university-of-medical-sciences.jpeg)
About this trial
This is an interventional diagnostic trial for Myocardial Infarction focused on measuring Myocardial infarction, artificial neural networks, Electrocardiography
Eligibility Criteria
Inclusion Criteria:
- patient with chest pain refered to ER with nondiagnostic ECG
Exclusion Criteria:
- 1) Absence of a history of myocardial infarction
- 2) Absence of bundle branch block, Wolf-Parkinson-White abnormality, ventricular hypertrophy or previous ECG signs of myocardial infarction,
- 3) Absence of a history of percutaneous coronary surgery or coronary artery bypass grafting,
- 4) Absence of ECG abnormalities attributable to drugs such as digoxin or tricyclic antidepressants.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Active Comparator
Arm Label
those without MI in 2 weeks
patient with MI
Arm Description
patient without MI in 2 weeks
group with MI in 2 weeks
Outcomes
Primary Outcome Measures
myocardial infarction
Secondary Outcome Measures
hospital admission due to cardiac events
may be includes unstable angina, cardiac arrest or PCIor CABG
Full Information
NCT ID
NCT01870258
First Posted
May 24, 2013
Last Updated
June 4, 2013
Sponsor
Shiraz University of Medical Sciences
1. Study Identification
Unique Protocol Identification Number
NCT01870258
Brief Title
Myocardial Infarction Prediction
Official Title
Prediction of Acute Myocardial Infarction With Artificial Neural Networks in Patients With Nondiagnostic Electrocardiogram
Study Type
Interventional
2. Study Status
Record Verification Date
June 2013
Overall Recruitment Status
Completed
Study Start Date
January 2011 (undefined)
Primary Completion Date
April 2012 (Actual)
Study Completion Date
June 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Shiraz University of Medical Sciences
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
prediction of MI in patients with chest pain and nondiagnostic ECG was done in 2 weeks
Detailed Description
Myocardial infarction remains one the leading causes of mortality and morbidity and involves a high cost of care. Early prediction can be helpful in preventing the development of myocardial infarction with appropriate diagnosis and treatment. Artificial neural networks have opened new horizons in learning about the natural history of diseases and predicting cardiac disease.
Methods: A total of 935 cardiac patients with chest pain and nondiagnostic electrocardiogram (ECG) were enrolled and followed for 2 weeks in two groups based on the appearance of myocardial infarction. Two types of data were used for all patients: nominal (clinical data) and quantitative (ECG findings). Two different artificial neural networks - radial basis function (RBF) and multi-layer perceptron (MLP) - were used.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myocardial Infarction, Artificial Neural Network
Keywords
Myocardial infarction, artificial neural networks, Electrocardiography
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Non-Randomized
Enrollment
1100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
those without MI in 2 weeks
Arm Type
Placebo Comparator
Arm Description
patient without MI in 2 weeks
Arm Title
patient with MI
Arm Type
Active Comparator
Arm Description
group with MI in 2 weeks
Intervention Type
Other
Intervention Name(s)
ANN prediction of myocardial infarction
Other Intervention Name(s)
sofware detected risk of new myocardial infraction
Primary Outcome Measure Information:
Title
myocardial infarction
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
hospital admission due to cardiac events
Description
may be includes unstable angina, cardiac arrest or PCIor CABG
Time Frame
2 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
72 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patient with chest pain refered to ER with nondiagnostic ECG
Exclusion Criteria:
1) Absence of a history of myocardial infarction
2) Absence of bundle branch block, Wolf-Parkinson-White abnormality, ventricular hypertrophy or previous ECG signs of myocardial infarction,
3) Absence of a history of percutaneous coronary surgery or coronary artery bypass grafting,
4) Absence of ECG abnormalities attributable to drugs such as digoxin or tricyclic antidepressants.
12. IPD Sharing Statement
Learn more about this trial
Myocardial Infarction Prediction
We'll reach out to this number within 24 hrs